Pharmaceutical Microbiology

Whether you need to ensure sterility, determine antimicrobial effectiveness, microbial contamination or bioburden, analyse endotoxins or identify flora from your environmental monitoring processes, we are here to help.

We will work with you as part of your team to not only provide comprehensive quality data but also timely and effective solutions to any challenges that you face.

We are fully GMP certified for quality control testing of human and veterinary medicinal products (full documentation is available to download on the right of this page). All Lucideon’s services are undertaken in compliance with EU guidance on GMP as it applies to contract QC testing laboratories.

We are MHRA-inspected (successfully re-accredited in September 2016), and a UKAS accredited testing house (No. 0013), so you can trust that the test data that we provide to you is accurate and reliable.  Our highly qualified and experienced technical staff use transparent, traceable, calibrated techniques and state-of-the-art equipment.

We have registered (self-identified) with the FDA (U.S. Food and Drugs Administration).  Please see our certificate here

Sterility Testing

We have a state-of-the-art, purpose-built sterility test isolator incorporating a vaporised hydrogen peroxide (VHP) generator, minimising the potential of false positives associated with other types of sterility testing environments.

We use two methods to perform sterility testing:

  • Membrane Filtration
  • Direct Inoculation.

Antimicrobial Efficacy Testing (AET)

At Lucideon, we can perform antimicrobial effectiveness testing (AET or PET) to Ph. Eur. and USP on an array of products. The product is inoculated with a specified number of each challenge organism. Over a period of 28 days the product is examined to determine the number of viable microorganisms which survive at each specified time interval.

Microbial Limits Testing

For non-sterile products, we can perform microbial contamination testing using harmonised pharmacopoeial or client-supplied methods to determine the bioburden within the sample. Microbial enumeration - Total Yeast and Mould Count (TYMC) and Total Aerobic Microbial Count (TAMC) analysis and tests for specified microorganisms are employed for this.

Bioburden Determination

Bioburden testing is performed by Lucideon to ensure that your products comply with the associated standards. Lucideon offers assessment of the quality of your production processes and can work with clients to produce solutions and improvements.

Bioburden testing is used in a number of situations as part of:

  • validation and revalidation of sterilization processes
  • routine monitoring for control of manufacturing processes
  • assessment of the efficiency of cleaning processes.

Endotoxin (LAL) Testing

We can perform analysis of endotoxins using Kinetic Turbidimetric methodology. Limulus Amoebocyte Lysate (LAL) is used to detect and quantify bacterial endotoxins extracted from the products.

Environmental Monitoring and Identification

Our experts can incubate, enumerate and identify flora from your environmental monitoring processes. Using a VITEK® 2 system to complement traditional Gram stain and microscopy techniques we are able to identify a vast library of environmental and clinical organisms to aid in background environmental analysis, failure investigations and contamination issues.

Water Analysis

Whether it's analysing water quality to pharmacopoeial monographs (Ph. Eur., USP, BP, JP), HTM directives, Microbiology of Drinking Water or Total Organic Carbon (TOC) - at Lucideon we can help.

Cleaning and Sterilization Validation of Reusable Medical Devices

Whether you need to ensure quality, source new raw materials or ensure the purity and stability of your existing ones, determine residual solvents in your products or confirm the stability of them, we are here to help.

Got a question?

Contact us here

Resources

  • White paper

    Additive Manufacturing - A Metallurgical Perspective

    pdf 4 MB

  • White paper

    Are you Ready for USP <232>/<233>?

    pdf 249 KB

  • White paper

    Quality by Design for the Pharmaceutical Industry

    pdf 835 KB

  • White paper

    Abuse Deterrence for the Pharmaceutical Market

    pdf 2 MB

  • White paper

    Surface Analysis Exposes Counterfeit Medicines

    pdf 479 KB

  • Newsletter

    Pharmaceutical Newsletter

    pdf 418 KB

Register or sign in below to access our resources.

Register

Forgot your password?